Denavir Topical and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Denavir Topical and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: penciclovir topical
Brand name: Denavir
Synonyms: Denavir Cream, Denavir
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denavir Topical-Insulin degludec
- Denavir Topical-Insulin Degludec (U-100) Prefilled Pens
- Denavir Topical-Insulin Degludec (U-100) Vials
- Denavir Topical-Insulin Degludec (U-200) Prefilled Pens
- Denavir Topical-Insulin degludec and liraglutide
- Denavir Topical-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dendracin Neurodendraxcin
- Insulin aspart, recombinant Subcutaneous-Denileukin Diftitox
- Insulin aspart, recombinant Subcutaneous-Denorex Extra Strength
- Insulin aspart, recombinant Subcutaneous-Denorex Topical
- Insulin aspart, recombinant Subcutaneous-Denosumab
- Insulin aspart, recombinant Subcutaneous-Denosumab Injection (Prolia)